METCAM/MUC18 augments migration, invasion, and tumorigenicity of human breast cancer SK-BR-3 cells

Gene

Volumn 492, Issue 1, 2012, Pages 229-238

  Zeng, Guofang ^a,b   Cai, Shaoxi ^a   Liu, Yuan ^b   Wu, Guang Jer ^b,c,d  

^a CHONGQING UNIVERSITY   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^d Department of BioScience Technology ^*  (Taiwan)

Author keywords

Human breast cancer SK BR 3; Human METCAM MUC18 expression; In vitro tumorigenesis; In vivo tumorigenesis; Motility invasiveness

Indexed keywords

CD146 ANTIGEN; COMPLEMENTARY DNA; PROTEIN BCL 2; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; BREAST CARCINOGENESIS; CANCER CELL; CANCER CELL CULTURE; CELL ANCHORAGE; CELL CLONE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GLYCOLYSIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

ANIMALS; ANTIGENS, CD146; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DISEASE PROGRESSION; FEMALE; GLYCOLYSIS; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC;

MUS MUSCULUS;

EID: 84155186418     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.10.024     Document Type: Article

References (39)

1. Anfosso F., et al. Outside-in signaling pathway linked to CD146 engagement in human endothelial cells. J. Biol. Chem. 2001, 146:1564-1569.
2. Analysis of proteins. Current Protocols in Molecular Biology 1987, Green Publishing Associates and Wiley-Interscience Press, New York, Section 10. F.M. Ausubel (Ed.).
3. In situ hybridization and immunohistochemistry. Current Protocols in Molecular Biology 1987, Green Publishing Associates and Wiley-Interscience Press, New York, Section 14. F.M. Ausubel (Ed.).
4. Benton G., et al. Advancing science and technology via 3D culture on basement membrane matrix. J. Cell. Physiol. 2009, 221:18-25.
5. Brown G.G. Basic staining: the hematoxylin and eosin technique. An introduction to histotechnology- a manual for the student, practicing technologist, and resident-in-pathology 1978, 207-216. Appleton-Century-Crofts, New York.
6. Cavallaro U., Christofori G. Cell adhesion and signaling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 2004, 4:118-132.
7. Charafe-Jauffret E., et al. Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 2006, 25:2273-2284.
8. Christofori G. Cancer: division of labor. Nature 2007, 446:735-736.
9. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three AKTs. Genes Dev. 1999, 13:2905-2927.
10. Fritz V., Fajas L. Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene 2010, 29:4369-4377.
11. Garcia S., et al. Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype. Hum. Pathol. 2007, 38:830-841.
12. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
13. Lee G.Y., et al. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat. Methods 2007, 4(4):359-365.
14. Lehmann J.M., Reithmuller G., Johnson J.P. MUC18, a marker of tumor progression in human melanoma. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:9891-9895.
15. Leone A., et al. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm-23 transfected melanoma cells. Cell 1991, 65:25-35.
16. Leslie M.C., et al. Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis. Gene Ther. 2007, 14:316-323.
17. Li G., et al. Reciprocal regulation of MELCAM and AKT in human melanoma. Oncogene 2003, 22:6891-6899.
18. Neve R.M., et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006, 10:515-527.
19. Noel A., et al. Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts. Br. J. Cancer 1993, 68:909-915.
20. Ouhtit A., et al. Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146. Biochim. Biophys. Acta 2009, 1795:130-136.
21. Passaniti A., et al. Stimulation of human prostatic carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix. Int. J. Cancer 1992, 51:318-324.
22. Schlagbauer-Wadl, et al. Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice. Int. J. Cancer 1999, 81:951-955.
23. Shih I.M. The role of CD146 (Mel-CAM) in biology and pathology. J. Pathol. 1999, 189:4-11.
24. Shih I.M., et al. The cell-cell adhesion receptor MEL-CAM acts as a tumor suppressor in breast carcinoma. Am. J. Pathol. 1997, 151:745-751.
25. Workman H.C., et al. Breast Cancer Res. 2009, 11:R70. 10.1186/bcr2364.
26. Wu G.J. Chapter 7: the role of MUC18 in prostate carcinoma. Molecular pathology, lung carcinoma, breast carcinoma, and prostate carcinoma 2004, vol 2:347-358. Elsevier Science/Academic Press. M.A. Hayat (Ed.).
27. Wu G.J. METCAM/MUC18 expression and cancer metastasis. Curr. Genomics 2005, 6:333-349.
28. Wu G.J. Chapter 8: the role of METCAM/MUC18 in tumorigenesis and hematogenous metastasis of several cancers. Horizons in Cancer Research 2010, 41:217-234. Nova Biomedical Books/Nova Science Publishers, New York. E.P. Morrison (Ed.).
29. Wu G.J., Son E.L. Soluble METCAM/MUC18 blocks angiogenesis during tumor formation of human prostate cancer cells. The proceedings of the 97th Annual Meeting of American Association for the Cancer Research 2006, 47. Abstract #252.
30. Wu G.J., et al. Identification of lactate dehydrogenase-M polypeptide translated in vitro from human and mouse tumor cell poly(A)-containing mRNA. Int. J. Biochem. 1985, 17:355-363.
31. Wu G.J., et al. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cells and tissues with malignant progression. Gene 2001, 279:17-31.
32. Wu G.J., et al. Ectopic expression of human MUC18 increases metastasis of human prostate cancer LNCaP cells. Gene 2004, 327:201-213.
33. Wu G.J., et al. Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model. Mol. Cancer Res. 2008, 6(11):1666-1677.
34. Wu G.J., Wu M.W.H., Liu Y. Enforced expression of human METCAM/MUC18 increases the tumorigenesis of human prostate cancer cells in nude mice. J. Urol. 2011, 185:1504-1512.
35. Xie S., et al. Expression of MCAM/MCU18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res. 1997, 57:2295-2303.
36. Yan X., et al. A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth. Blood 2003, 102(1):184-191.
37. Yang H., et al. Isolation and characterization of murine MUC18 cDNA gene, and correlation of MUC18 expression in murine melanoma cell lines with metastatic ability. Gene 2001, 265:133-145.
38. Zabouo G., et al. CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines. Breast Cancer Res. 2009, 11:R1. 10.1186/bcr2215.
39. Zeng G., Cai S.X., Wu G.J. Up-regulation of METCAM/MUC18 promotes motility, invasion, and tumorigenesis of human breast cancer cells. BMC Cancer 2011, 11:113. (30 March, 2011). 10.1186/1471-2407-11-113.